Abbott Laboratories Stock Short Ratio

ABT Stock

USD 117.26 1.33 1.15%

Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Abbott Laboratories Company Short Ratio Analysis

Abbott Laboratories' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current Abbott Laboratories Short Ratio

2.83 X

Most of Abbott Laboratories' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Abbott Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Abbott Laboratories is extremely important. It helps to project a fair market value of Abbott Stock properly, considering its historical fundamentals such as Short Ratio. Since Abbott Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbott Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbott Laboratories' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Current Deferred Revenue	Short Term Investments	Common Stock	Intangible Assets	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Long Term Debt Total	Long Term Investments	Accumulated Depreciation	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.75	0.77	0.61	0.86	0.97	0.74	-0.16	0.63	-0.3	-0.06	0.05	0.74	0.78	-0.62	0.8	0.88	-0.34	0.58	-0.23	-0.35	0.26	-0.54	-0.18	-0.33	0.04
Total Stockholder Equity	0.75		0.55	0.93	0.66	0.65	0.49	-0.05	0.89	-0.36	-0.06	-0.1	0.58	0.53	-0.74	0.83	0.81	0.01	0.38	-0.24	-0.47	0.35	-0.7	-0.65	-0.39	0.65
Net Debt	0.77	0.55		0.29	0.6	0.81	0.26	-0.42	0.49	-0.14	-0.2	0.01	0.98	0.8	-0.39	0.58	0.86	-0.73	0.71	-0.27	-0.22	-0.01	-0.73	-0.33	-0.58	-0.03
Retained Earnings	0.61	0.93	0.29		0.52	0.5	0.5	0.1	0.8	-0.42	-0.09	-0.16	0.31	0.39	-0.81	0.7	0.59	0.27	0.24	0.02	-0.36	0.45	-0.51	-0.59	-0.24	0.7
Net Receivables	0.86	0.66	0.6	0.52		0.84	0.77	0.07	0.54	-0.05	0.21	0.38	0.52	0.54	-0.27	0.82	0.73	-0.2	0.36	-0.42	-0.6	0.09	-0.31	-0.13	-0.18	0.09
Total Liab	0.97	0.65	0.81	0.5	0.84		0.75	-0.21	0.54	-0.24	-0.07	0.13	0.76	0.88	-0.52	0.72	0.82	-0.45	0.7	-0.19	-0.36	0.21	-0.48	-0.13	-0.29	-0.02
Total Current Assets	0.74	0.49	0.26	0.5	0.77	0.75		0.19	0.28	-0.31	0.34	0.18	0.18	0.56	-0.36	0.52	0.38	0.06	0.34	-0.14	-0.32	0.27	0.06	0.17	0.18	-0.03
Short Term Debt	-0.16	-0.05	-0.42	0.1	0.07	-0.21	0.19		-0.32	-0.3	0.43	0.33	-0.4	-0.5	0.07	-0.24	-0.38	0.42	-0.72	-0.05	0.2	0.04	0.56	0.31	0.4	-0.08
Accounts Payable	0.63	0.89	0.49	0.8	0.54	0.54	0.28	-0.32		-0.02	-0.32	-0.15	0.52	0.47	-0.64	0.87	0.82	0.04	0.45	-0.23	-0.67	0.43	-0.81	-0.77	-0.47	0.74
Current Deferred Revenue	-0.3	-0.36	-0.14	-0.42	-0.05	-0.24	-0.31	-0.3	-0.02		-0.07	0.11	-0.23	-0.23	0.59	0.06	-0.1	0.02	0.03	-0.11	-0.56	-0.05	0.07	0.01	0.04	0.04
Short Term Investments	-0.06	-0.06	-0.2	-0.09	0.21	-0.07	0.34	0.43	-0.32	-0.07		0.05	-0.26	-0.23	0.33	-0.14	-0.26	0.21	-0.35	-0.28	-0.02	-0.27	0.46	0.31	0.32	-0.2
Common Stock	0.05	-0.1	0.01	-0.16	0.38	0.13	0.18	0.33	-0.15	0.11	0.05		-0.01	-0.06	0.42	0.07	-0.04	-0.14	-0.11	-0.18	-0.22	-0.15	0.27	0.21	0.18	-0.16
Intangible Assets	0.74	0.58	0.98	0.31	0.52	0.76	0.18	-0.4	0.52	-0.23	-0.26	-0.01		0.76	-0.46	0.53	0.86	-0.74	0.65	-0.27	-0.16	0.0	-0.78	-0.39	-0.58	0.02
Long Term Debt	0.78	0.53	0.8	0.39	0.54	0.88	0.56	-0.5	0.47	-0.23	-0.23	-0.06	0.76		-0.5	0.52	0.69	-0.54	0.93	-0.01	-0.23	0.19	-0.54	-0.22	-0.29	0.04
Treasury Stock	-0.62	-0.74	-0.39	-0.81	-0.27	-0.52	-0.36	0.07	-0.64	0.59	0.33	0.42	-0.46	-0.5		-0.46	-0.57	-0.02	-0.31	-0.28	-0.05	-0.41	0.56	0.42	0.32	-0.37
Property Plant Equipment	0.8	0.83	0.58	0.7	0.82	0.72	0.52	-0.24	0.87	0.06	-0.14	0.07	0.53	0.52	-0.46		0.88	-0.04	0.47	-0.38	-0.73	0.31	-0.64	-0.47	-0.38	0.47
Good Will	0.88	0.81	0.86	0.59	0.73	0.82	0.38	-0.38	0.82	-0.1	-0.26	-0.04	0.86	0.69	-0.57	0.88		-0.41	0.6	-0.34	-0.5	0.23	-0.83	-0.5	-0.57	0.29
Net Tangible Assets	-0.34	0.01	-0.73	0.27	-0.2	-0.45	0.06	0.42	0.04	0.02	0.21	-0.14	-0.74	-0.54	-0.02	-0.04	-0.41		-0.53	0.16	-0.1	0.39	0.33	-0.08	0.23	0.41
Long Term Debt Total	0.58	0.38	0.71	0.24	0.36	0.7	0.34	-0.72	0.45	0.03	-0.35	-0.11	0.65	0.93	-0.31	0.47	0.6	-0.53		-0.01	-0.32	0.19	-0.56	-0.27	-0.28	0.14
Long Term Investments	-0.23	-0.24	-0.27	0.02	-0.42	-0.19	-0.14	-0.05	-0.23	-0.11	-0.28	-0.18	-0.27	-0.01	-0.28	-0.38	-0.34	0.16	-0.01		0.44	0.07	0.19	0.12	0.13	-0.08
Accumulated Depreciation	-0.35	-0.47	-0.22	-0.36	-0.6	-0.36	-0.32	0.2	-0.67	-0.56	-0.02	-0.22	-0.16	-0.23	-0.05	-0.73	-0.5	-0.1	-0.32	0.44		-0.28	0.35	0.44	0.13	-0.55
Short Long Term Debt	0.26	0.35	-0.01	0.45	0.09	0.21	0.27	0.04	0.43	-0.05	-0.27	-0.15	0.0	0.19	-0.41	0.31	0.23	0.39	0.19	0.07	-0.28		-0.24	-0.24	-0.17	0.38
Cash And Equivalents	-0.54	-0.7	-0.73	-0.51	-0.31	-0.48	0.06	0.56	-0.81	0.07	0.46	0.27	-0.78	-0.54	0.56	-0.64	-0.83	0.33	-0.56	0.19	0.35	-0.24		0.81	0.81	-0.48
Net Invested Capital	-0.18	-0.65	-0.33	-0.59	-0.13	-0.13	0.17	0.31	-0.77	0.01	0.31	0.21	-0.39	-0.22	0.42	-0.47	-0.5	-0.08	-0.27	0.12	0.44	-0.24	0.81		0.69	-0.8
Net Working Capital	-0.33	-0.39	-0.58	-0.24	-0.18	-0.29	0.18	0.4	-0.47	0.04	0.32	0.18	-0.58	-0.29	0.32	-0.38	-0.57	0.23	-0.28	0.13	0.13	-0.17	0.81	0.69		-0.17
Capital Stock	0.04	0.65	-0.03	0.7	0.09	-0.02	-0.03	-0.08	0.74	0.04	-0.2	-0.16	0.02	0.04	-0.37	0.47	0.29	0.41	0.14	-0.08	-0.55	0.38	-0.48	-0.8	-0.17

Click cells to compare fundamentals

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.

Competition

Predict Abbott Laboratories

Abbott Discontinued Operations

Discontinued Operations

20.52 Million

At this time, Abbott Laboratories' Discontinued Operations is comparatively stable compared to the past year.

Based on the latest financial disclosure, Abbott Laboratories has a Short Ratio of 2.83 times. This is 27.44% lower than that of the Health Care Equipment & Supplies sector and 24.93% lower than that of the Health Care industry. The short ratio for all United States stocks is 29.25% higher than that of the company.

Abbott Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.

Abbott Laboratories is currently under evaluation in short ratio category among its peers.

Abbott Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Abbott Laboratories from analyzing Abbott Laboratories' financial statements. These drivers represent accounts that assess Abbott Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbott Laboratories' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	99.5B	127.0B	249.8B	190.9B	171.8B	180.4B
Enterprise Value	118.0B	142.7B	259.0B	199.8B	179.9B	188.9B

Abbott Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.

Environmental

Governance

Social

Abbott Laboratories Institutional Holders

Institutional Holdings refers to the ownership stake in Abbott Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Abbott Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Abbott Laboratories' value.

		Shares
Wells Fargo & Co	2024-06-30	16.8 M
Jpmorgan Chase & Co	2024-06-30	14.8 M
Legal & General Group Plc	2024-06-30	14.3 M
Bank Of New York Mellon Corp	2024-06-30	14.2 M
Polen Capital	2024-09-30	13.9 M
State Farm Mutual Automobile Ins Co	2024-09-30	13.6 M
Massachusetts Financial Services Company	2024-09-30	13.3 M
Charles Schwab Investment Management Inc	2024-09-30	12.6 M
Fisher Asset Management, Llc	2024-09-30	11.1 M
Vanguard Group Inc	2024-09-30	167.9 M
Blackrock Inc	2024-06-30	131.1 M

Abbott Fundamentals

	Return On Equity	0.15
	Return On Asset	0.0649
	Profit Margin	0.14 %
	Operating Margin	0.19 %
	Current Valuation	208.27 B
	Shares Outstanding	1.73 B
	Shares Owned By Insiders	0.53 %
	Shares Owned By Institutions	77.50 %
	Number Of Shares Shorted	14.07 M
	Price To Earning	24.14 X
	Price To Book	5.05 X
	Price To Sales	4.93 X
	Revenue	40.11 B
	Gross Profit	24.58 B
	EBITDA	10.46 B
	Net Income	5.72 B
	Cash And Equivalents	9.88 B
	Cash Per Share	5.68 X
	Total Debt	15.87 B
	Debt To Equity	0.46 %
	Current Ratio	1.86 X
	Book Value Per Share	22.94 X
	Cash Flow From Operations	7.26 B
	Short Ratio	2.83 X
	Earnings Per Share	3.29 X
	Price To Earnings To Growth	2.25 X
	Target Price	129.87
	Number Of Employees	114 K
	Beta	0.72
	Market Capitalization	203.38 B
	Total Asset	73.21 B
	Retained Earnings	37.55 B
	Working Capital	8.83 B
	Current Asset	14.15 B
	Current Liabilities	9.19 B
	Annual Yield	0.02 %
	Five Year Return	1.54 %
	Net Asset	73.21 B
	Last Dividend Paid	2.2

About Abbott Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC